drugset / Trial / NCT05836883
Study of ExoFlo for the Treatment of Perianal Fistulas
RandomizedSequentialSingle-blindTreatment
Summary
To evaluate the safety and feasibility of ExoFlo as a treatment for Perianal Fistulizing Crohn's Disease.
Timeline
- Start
- 2023-08-28
- Primary completion
- 2024-12-01
- Completion
- 2024-12-01
Outcome
Outcome not reported
Stopped (Enrollment): “Enrollment challenges.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ExoFlo | Other / unclassified | 15 ml | Other |
| Subject | ExoFlo | Other / unclassified | 30 ml | Other |